Edesa Biotech Statistics

Total Valuation

Edesa Biotech has a market cap or net worth of $14.94 million. The enterprise value is $12.20 million.

Market Cap	14.94M
Enterprise Value	12.20M

Important Dates

The last earnings date was Friday, May 10, 2024, after market close.

Earnings Date	May 10, 2024
Ex-Dividend Date	n/a

Share Statistics

Edesa Biotech has 3.22 million shares outstanding. The number of shares has increased by 11.89% in one year.

Shares Outstanding	3.22M
Shares Change (YoY)	+11.89%
Shares Change (QoQ)	+2.07%
Owned by Insiders (%)	28.45%
Owned by Institutions (%)	10.73%
Float	2.33M

Valuation Ratios

PE Ratio	n/a
Forward PE	0.17
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.46
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.97, with a Debt / Equity ratio of 0.01.

Current Ratio	1.97
Quick Ratio	1.82
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -115.60% and return on invested capital (ROIC) is -194.22%.

Return on Equity (ROE)	-115.60%
Return on Assets (ROA)	-88.90%
Return on Capital (ROIC)	-194.22%
Revenue Per Employee	n/a
Profits Per Employee	-$452,814
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Edesa Biotech has paid $800 in taxes.

Income Tax	800
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.79% in the last 52 weeks. The beta is 0.88, so Edesa Biotech's price volatility has been lower than the market average.

Beta (1Y)	0.88
52-Week Price Change	-29.79%
50-Day Moving Average	4.43
200-Day Moving Average	4.63
Relative Strength Index (RSI)	52.61
Average Volume (30 Days)	8,341

Short Selling Information

The latest short interest is 16,127, so 0.50% of the outstanding shares have been sold short.

Short Interest	16,127
Short Previous Month	15,197
Short % of Shares Out	0.50%
Short % of Float	0.69%
Short Ratio (days to cover)	3.16

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.51M
Pretax Income	-7.24M
Net Income	-7.25M
EBITDA	-7.02M
EBIT	-7.24M
Earnings Per Share (EPS)	-$2.37

Full Income Statement

Balance Sheet

The company has $2.80 million in cash and $58,143 in debt, giving a net cash position of $2.74 million or $0.85 per share.

Cash & Cash Equivalents	2.80M
Total Debt	58,143
Net Cash	2.74M
Net Cash Per Share	$0.85
Equity / Book Value	4.32M
Book Value Per Share	1.34
Working Capital	2.09M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-6.34M
Capital Expenditures	n/a
Free Cash Flow	-6.34M
FCF Per Share	-$1.99

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Edesa Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.89%
Shareholder Yield	-11.89%
Earnings Yield	-48.49%
FCF Yield	-42.43%

Analyst Forecast

The average price target for Edesa Biotech is $39.00, which is 757.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$39.00
Price Target Difference	757.14%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 11, 2023. It was a reverse split with a ratio of 1:7.

Last Split Date	Oct 11, 2023
Split Type	Reverse
Split Ratio	1:7

Scores

Altman Z-Score	n/a
Piotroski F-Score	1